Daniel Loeb
Third Point
Daniel Loeb Merck & Company Inc stake
total: 588
Third Point MRK trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2018 Q3
- Held for:
- 2 quarters
- Latest activity:
- 2019 Q1
According to 2026 Q2 report, Daniel Loeb doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $70.94 for "buy" trades and estimated average "sell" price is $76.41. Third Point first purchased MRK in 2018 Q3, initially acquiring about 4.50M shares. Since the initial investment in Merck & Company Inc (MRK), Third Point has made 2 more transactions.
When did Daniel Loeb sell Merck & Company Inc (MRK)?
Daniel Loeb sold off the entire Merck & Company Inc (MRK) position in 2019 Q1.
When did Daniel Loeb buy Merck & Company Inc (MRK)?
Daniel Loeb first invested in Merck & Company Inc (MRK) in 2018 Q3 at the reported quarter-end price of $70.94 per share.
What's the cost basis of Third Point's MRK stake?
The estimated cost basis for Merck & Company Inc (MRK) stake is around $70.94 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $70.94
- Weighted AVG sell price:
- $76.41
Daniel Loeb's historical trades in Merck & Company Inc
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.